Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR279356 for Infection Prophylaxis in ICU Patients
NCT01389700Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Oct 2011
- Primary completion
- Dec 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of F598 in Staphylococcus aureus infection, sponsored by Sanofi. Started Oct 2011; status: terminated.
02
Drugs
F598
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT01389700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01389700.